Tag Archives: Dynamical Biomarkers Group

Qualcomm Tricorder XPrize Winners Announced

Peter Lobner

In my 24 December 2016 post, I reported that the Qualcomm Tricorder XPrize committee had selected two teams to continue into the finals: Dynamical Biomarkers Group and Final Frontier Medical Devices.   On 12 April 2017, the Qualcomm Tricorder XPrize committee announced the winners…and yes, there were two winners:

“Of the 300 teams that joined the pursuit of the Qualcomm Tricorder XPRIZE, Final Frontier Medical Devices and Dynamical Biomarkers Group were both announced winners at the Qualcomm Tricorder XPRIZE awards ceremony on April 12, 2017.

Final Frontier Medical Devices was announced the highest performing team and received $2.5M for their achievement and Dynamical Biomarkers Group received $1M for 2nd place. Both teams exceeded the competition requirements for user experience, nearly met the challenging audacious benchmarks for diagnosing the 13 disease states, and with their prototypes, have taken humanity one step closer to realizing Gene Roddenberry’s 23rd century sci-fi vision. XPRIZE congratulates Final Frontier Medical Devices and Dynamical Biomarkers Group on their amazing achievements.”

Learn more about Final Frontier Medical Devices and their winning tricorder named DxtER here:


Learn more about Dynamical Biomarkers Group and their 2nd place tricorder system comprised of three modules here:


OK, neither XPrize tricorder prototype looks like Dr. McCoy’s hand-held tricorder seen on Star Trek (the original series), but the automated diagnostic capabilities offered by the XPrize tricorder prototypes really are a giant leap forward in the development of tricorder technology for the real world. The Qualcomm Tricorder XPrize competition has been successful in making this happen on an accelerated schedule.

McCoy and his tricorder. Source: Star Trek (the original series), Desilu Productions

Star Trek Tricorder replica. Source: Amazon.com

Qualcomm Tricorder XPrize Competition Down to Two Finalists

Peter Lobner

I described the Qualcomm Tricorder XPrize competition in my 10 March 2015 post, “Medical Tricorder Technology is Closer Than you Think.” The goal of the competition is to develop a real-world equivalent of the Star Trek Tricorder, with the following basic capabilities and features:

  • Diagnose at least 13 different health conditions including the following nine required conditions: anemia, atrial fibrillation, chronic obstructive pulmonary disease, diabetes, leukocytosis, pneumonia, ottis media, sleep apnea and urinary tract infection.
  • Weigh less than five pounds

At the time of my last update in December 2015, the following seven teams had been selected to compete in the extended Final Round for $10 million in prize money.

  • Aezon (U.S.)
  • Clouddx (Canada)
  • Danvantri (India)
  • DMI (U.S.)
  • Dynamical Biomarkers Group (Taiwan)
  • Final Frontier Medical Devices (U.S.)
  • Intellesens-Scanadu (UK)

Each of these teams submitted their final working prototypes for evaluation in Q3 2016. On 13 December 2016, Qualcomm Tricorder XPrize announced that they had selected two teams to continue into the finals:

“Congratulations to our two final teams, Dynamical Biomarkers Group and Final Frontier Medical Devices, who will proceed to the final phase in the $10M Qualcomm Tricorder XPRIZE. Both teams’ devices will undergo consumer testing over the next few months at the Altman Clinical Translational Research Institute at the University of California San Diego, and the winner will be announced in Q2, 2017.”

Both teams are required to deliver 45 kits for testing.

The XPrize will be split with $6 million going to the winning team, $2 million going to the runner-up, and $1 million for the team that receives the highest vital signs score in the final round. An additional $1M already has been awarded in milestone prizes.

The two competing devices are briefly described below. For more information, visit the Qualcomm Tricorder XPrize website at the following link:


Dynamical Biomarkers Group

DBG_TricorderSource: Qualcomm Tricorder XPrize

 Key system features:

  • Comprised of three modules: Smart Vital-Sense Monitor; Smart Blood-Urine Test Kit; Smart Scope Module.
  • Includes technologies for physiologic signal analysis, image processing, and biomarker detection.
  • Smartphone app executes simple, interactive screening process that guides the users to carry out specific tests to generate disease diagnosis. The phone’s on-board camera is used to capture images of test strips. The smartphone communicates to the base unit via Bluetooth.
  • The base unit uploads collected data to a remote server for analysis.

Final Frontier Medical Devices: DxtER

DexTR_TricorderSource: Qualcomm Tricorder XPrize

Key system features:

  • DxtER is designed as a consumer product for monitoring your health and diagnosing illnesses in the comfort of your own home.
  • Non-invasive sensors collect data about your vital signs, body chemistry, and biological functions.
  • An iPad Mini with an on-board AI diagnostic app synthesizes the health data to generate a diagnosis.
  • While DxtER functions autonomously, it also can share data with a remote healthcare provider.

Best wishes to both teams as they enter the final round of this challenging competition, which could significantly change the way some basic medical services are delivered in the U.S. and around the world.